A detailed history of American Century Companies Inc transactions in Abbott Laboratories stock. As of the latest transaction made, American Century Companies Inc holds 704,935 shares of ABT stock, worth $79.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
704,935
Previous 825,374 14.59%
Holding current value
$79.9 Million
Previous $93.8 Million 21.92%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $12.1 Million - $13.5 Million
-120,439 Reduced 14.59%
704,935 $73.2 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $3.2 Million - $3.53 Million
-29,219 Reduced 3.42%
825,374 $93.8 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $77.1 Million - $94.3 Million
854,593 New
854,593 $94.1 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $9 Million - $10.8 Million
-94,188 Reduced 7.37%
1,184,001 $115 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $27.3 Million - $30.4 Million
270,485 Added 26.84%
1,278,189 $139 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $4.48 Million - $5.28 Million
46,297 Added 4.82%
1,007,704 $102 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $35.6 Million - $41.7 Million
-374,289 Reduced 28.02%
961,407 $106 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $21.5 Million - $24.9 Million
222,042 Added 19.94%
1,335,696 $129 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $26.6 Million - $32.2 Million
-261,031 Reduced 18.99%
1,113,654 $121 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $21.1 Million - $25.7 Million
-184,901 Reduced 11.86%
1,374,685 $163 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $23.7 Million - $29.1 Million
205,534 Added 15.18%
1,559,586 $219 Million
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $57.6 Million - $63.7 Million
493,468 Added 57.34%
1,354,052 $160 Million
Q2 2021

Aug 05, 2021

SELL
$105.79 - $124.53 $141 Million - $166 Million
-1,336,417 Reduced 60.83%
860,584 $99.8 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $89.2 Million - $105 Million
-819,523 Reduced 27.17%
2,197,001 $263 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $138 Million - $150 Million
-1,314,055 Reduced 30.34%
3,016,524 $330 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $24 Million - $29.2 Million
-262,159 Reduced 5.71%
4,330,579 $471 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $40.9 Million - $52.3 Million
534,002 Added 13.16%
4,592,738 $420 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $13.3 Million - $19.5 Million
212,253 Added 5.52%
4,058,736 $320 Million
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $17.3 Million - $19.2 Million
220,021 Added 6.07%
3,846,483 $334 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $31.2 Million - $33.8 Million
-381,362 Reduced 9.52%
3,626,462 $303 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $29,297 - $34,170
-402 Reduced 0.01%
4,007,824 $337 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $38.8 Million - $47 Million
-586,568 Reduced 12.77%
4,008,226 $0
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $102 Million - $115 Million
-1,554,564 Reduced 25.28%
4,594,794 $332 Million
Q3 2018

Nov 02, 2018

BUY
$60.81 - $73.36 $34.3 Million - $41.3 Million
563,239 Added 10.08%
6,149,358 $451 Million
Q2 2018

Aug 08, 2018

BUY
$57.57 - $63.54 $259 Million - $286 Million
4,507,553 Added 417.92%
5,586,119 $341 Million
Q1 2018

May 03, 2018

SELL
$56.27 - $63.62 $43.8 Million - $49.6 Million
-778,959 Reduced 41.94%
1,078,566 $64.6 Million
Q4 2017

Feb 02, 2018

SELL
$53.68 - $57.47 $8.07 Million - $8.64 Million
-150,412 Reduced 7.49%
1,857,525 $106 Million
Q3 2017

Nov 01, 2017

BUY
$48.06 - $53.64 $96.5 Million - $108 Million
2,007,937
2,007,937 $107 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.